Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,409 total articles

NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications

NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications

PMGC Holdings Inc.'s subsidiary, NorthStrive Defense Tech, has entered into a binding agreement to exclusively license a patented multi-domain drone payload technology, enabling drones to autonomously transport cable-suspended payloads across air and water using buoyancy assistance. The technology targets defense, aerospace, and maritime sectors wi…

Standard BioTools and Treeline Biosciences Announce Merger Agreement

Standard BioTools and Treeline Biosciences Announce Merger Agreement

Standard BioTools (NASDAQ: LAB) and Treeline Biosciences have entered a definitive merger agreement to combine into a single company operating as Treeline Biosciences under the ticker TRLN. The combined entity will focus on developing a pipeline of small molecule inhibitors, protein degraders, and targeted therapy antibody-drug conjugates, primaril…

Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA

Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA

Zevra Therapeutics has successfully submitted a U.S. patent for its drug MIPLYFFA to the FDA's Orange Book, strengthening its intellectual property protection with exclusivity extending to 2041. This development solidifies Zevra's position in treating Niemann-Pick disease type C and enhances the long-term commercial value of MIPLYFFA. A patent term…

Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

Medicus Pharma announced the submission of a substantial modification application to advance its Teverelix® Phase 2b trial in Europe, targeting advanced prostate cancer patients with heightened cardiovascular risk. The trial aims to optimize dosing and support registrational development, addressing a significant unmet need in prostate cancer treatm…

Caliber to Present at Planet MicroCap Las Vegas 2026

Caliber to Present at Planet MicroCap Las Vegas 2026

Caliber, a Nasdaq-listed real estate alternative asset manager, announced it will present at the Planet MicroCap Las Vegas 2026 conference. The presentation will highlight the company's progress toward consistent profitability, capital structure improvements, real estate investment strategies in key U.S. markets, and its pioneering use of tokenizat…

Anfield Energy Provides Operational Update on Shootaring Canyon Uranium Mill License Renewal and Refurbishment

Anfield Energy Provides Operational Update on Shootaring Canyon Uranium Mill License Renewal and Refurbishment

Anfield Energy Inc. provides an operational update on the Shootaring Canyon Uranium Mill license renewal and refurbishment progress in Utah. Key milestones include drilling monitoring wells, starting leach tank removal, progressing engineering designs, and constructing a new man camp. These efforts aim to complete license renewal by year-end and re…

Ambow Education to Host HybriU™ Open House at NewSchool of Architecture and Design During AIA Conference on Architecture & Design 2026 in San Diego

Ambow Education to Host HybriU™ Open House at NewSchool of Architecture and Design During AIA Conference on Architecture & Design 2026 in San Diego

Ambow Education Holding Ltd. (NYSE American: AMBO) announced it will host a multi-day Open House event at the NewSchool of Architecture and Design during the AIA Conference on Architecture & Design 2026 in San Diego. The event will showcase Ambow's patented AI-powered phygital platform, HybriU™, which enables real-time, immersive collaboration and …

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Ceribell announced the publication of a pivotal research paper in Critical Care Medicine demonstrating that their Clarity AI algorithm’s measurement of seizure burden strongly correlates with neurological outcomes at discharge. The study, conducted across three academic medical centers on 359 patients, shows that higher seizure burden detected by C…

Eldorado Gold Announces First Concentrate Produced at McIlvenna Bay

Eldorado Gold Announces First Concentrate Produced at McIlvenna Bay

Eldorado Gold Corporation announced the production of the first copper concentrate at its 100%-owned McIlvenna Bay Project in Saskatchewan, Canada. This milestone marks a key step towards achieving commercial production targeted for Q3 2026. The project diversifies Eldorado's portfolio by adding copper and zinc exposure and enhances its Canadian op…

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Eledon Pharmaceuticals announced updated data from an investigator-initiated trial at UChicago Medicine demonstrating that all 12 patients with Type 1 Diabetes undergoing islet transplantation achieved insulin independence and improved glycemic control using tegoprubart, a novel anti-CD40L antibody. The calcineurin inhibitor-free regimen showed exc…

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion, Inc., a Nasdaq-listed healthcare technology company specializing in chronic low back pain diagnostics, announced that its stockholders approved all proposals at the 2026 Annual Meeting, including board member elections, auditor appointment, and equity plan amendments. The company reported 196% year-over-year growth in its Nociscan scan vo…

Concorde International Group Enters Exclusive Partnership with TrackerHero, Onboarding Its Business Model–Driven, Technology-Enabled Facilities Security Operations

Concorde International Group Enters Exclusive Partnership with TrackerHero, Onboarding Its Business Model–Driven, Technology-Enabled Facilities Security Operations

Concorde International Group Ltd. (NASDAQ: YOOV), a provider of technology-enabled security solutions, has entered into an exclusive strategic partnership with Malaysia-based TrackerHero to integrate TrackerHero's AI and IoT-powered digital patrol management system, THPatrol, into Concorde's facilities security operations in Singapore. The collabor…

Brady Corporation Announces CEO Transition

Brady Corporation Announces CEO Transition

Brady Corporation announced that Russell Shaller will retire after 11 years as CEO and board member, with Vineet Nargolwala appointed as the new CEO effective June 8, 2026. Nargolwala brings extensive experience in technology and public companies and will lead Brady through its major acquisition of Honeywell’s Productivity Solutions and Services bu…

EHang Announces US$30 Million Share Repurchase Program

EHang Announces US$30 Million Share Repurchase Program

EHang Holdings Limited, a leading advanced air mobility technology company listed on Nasdaq, announced a $30 million share repurchase program over the next 12 months. The company's board authorized buying back shares to demonstrate confidence in its long-term growth and value delivery to shareholders. The repurchase will be funded mainly from exist…

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026

Upstream Bio announced that new data from its Phase 2 VIBRANT trial evaluating verekitug, a novel TSLP receptor antagonist monoclonal antibody, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) will be presented at the EAACI 2026 Congress. Verekitug is uniquely positioned as the only antagonist targeting the TSLP receptor in clinic…

Quantum Cyber Signs LOI to Acquire an Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility to Support Mass-Scale Autonomous Drone Production

Quantum Cyber Signs LOI to Acquire an Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility to Support Mass-Scale Autonomous Drone Production

Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announced its wholly owned subsidiary Quantum Drones Corporation has signed a Letter of Intent to acquire a manufacturing facility in Bridgeport, Connecticut. The acquisition supports the company's strategic shift from technology licensing to vertically integrated manufactur…